GPC3 and hepatocellular carcinoma: In this study, we designed a novel croconaine-based GPC-3 targeting agent, CR-PEG-GBP, to achieve NIR-II fluorescence and PA imaging-guided PTT and SDT for HCC photo-sonotheranostics.